Your session is about to expire
← Back to Search
Aerobic Exercise for Type 2 Diabetes (EPC-DM Trial)
N/A
Waitlist Available
Research Sponsored by Baltimore VA Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
If woman, postmenopausal >1 year
Age 50-80
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-month
Awards & highlights
EPC-DM Trial Summary
This trial is designed to study how well exercise training works to improve cardiovascular function in people with type 2 diabetes, as well as the mechanisms underlying Endothelial Progenitor Cell (EPC) dysfunction in this population.
Who is the study for?
This trial is for non-smoking adults aged 50-80 with type 2 diabetes, particularly those who are sedentary. Women must be postmenopausal for over a year. It's not suitable for individuals with kidney or liver diseases, uncontrolled high blood pressure or cholesterol levels, or a history of cancer, heart disease, or stroke.Check my eligibility
What is being tested?
The study is testing whether aerobic exercise training can improve the function and number of endothelial progenitor cells (EPCs) in older adults with type 2 diabetes. The goal is to see if this leads to better blood vessel health and glucose metabolism.See study design
What are the potential side effects?
Aerobic exercise is generally safe but may include muscle soreness, fatigue, and an increased risk of injury. Specific side effects will depend on individual health status and exercise intensity.
EPC-DM Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman who has been postmenopausal for more than a year.
Select...
I am between 50 and 80 years old.
EPC-DM Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Endothelial progenitor cell number
Skeletal muscle capillarization
Secondary outcome measures
Cardiorespiratory Fitness
EPC-DM Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: T2DMExperimental Treatment1 Intervention
Type 2 Diabetes Mellitus
Group II: IGTExperimental Treatment1 Intervention
Impaired Glucose Tolerance
Group III: NGTActive Control1 Intervention
Normal Glucose Tolerance
Find a Location
Who is running the clinical trial?
Baltimore VA Medical CenterLead Sponsor
32 Previous Clinical Trials
3,055 Total Patients Enrolled
University of Maryland, BaltimoreOTHER
687 Previous Clinical Trials
374,576 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My blood pressure or cholesterol levels are not well-managed.You do not smoke cigarettes.I have had cancer in the past.I have a kidney or liver disease.I am a woman who has been postmenopausal for more than a year.I am between 50 and 80 years old.I have a history of heart disease or stroke.
Research Study Groups:
This trial has the following groups:- Group 1: T2DM
- Group 2: NGT
- Group 3: IGT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there currently any openings for individuals to participate in this clinical trial?
"According to clinicaltrials.gov, this research project is no longer actively seeking participants; it was originally posted on July 1st 2011 and last updated February 28th 2022. Nonetheless, 871 other trials are currently accepting patients into their studies."
Answered by AI
Are seniors being recruited as participants of this clinical investigation?
"This medical trial is recruiting patients aged 50 to 80 years old."
Answered by AI
Is it possible to participate in this experiment?
"To be included in this study, interested individuals must have type 2 diabetes mellitus and fall between the ages of 50-80. The clinical trial is looking to enrol 70 patients total."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger